116 related articles for article (PubMed ID: 20308534)
1. Tumor-infiltrating lymphocytes and mitotic index in metastatic melanoma as predictors of patient survival.
Murali R; Scolyer RA
Proc Natl Acad Sci U S A; 2010 Mar; 107(13):E46; author reply E47. PubMed ID: 20308534
[No Abstract] [Full Text] [Related]
2. 2010 TNM staging system for cutaneous melanoma...and beyond.
Gershenwald JE; Soong SJ; Balch CM;
Ann Surg Oncol; 2010 Jun; 17(6):1475-7. PubMed ID: 20300965
[No Abstract] [Full Text] [Related]
3. Dendritic cell density and activation status of tumour-infiltrating lymphocytes in metastatic human melanoma: possible implications for sentinel node metastases.
Barbour AH; Coventry BJ
Melanoma Res; 2003 Jun; 13(3):263-9. PubMed ID: 12777981
[TBL] [Abstract][Full Text] [Related]
4. Predictors of sentinel lymph node status in cutaneous melanoma: a classification and regression tree analysis.
Tejera-Vaquerizo A; Martín-Cuevas P; Gallego E; Herrera-Acosta E; Traves V; Herrera-Ceballos E; Nagore E
Actas Dermosifiliogr; 2015 Apr; 106(3):208-18. PubMed ID: 25616352
[TBL] [Abstract][Full Text] [Related]
5. Progress in melanoma histopathology and diagnosis.
Piris A; Mihm MC
Hematol Oncol Clin North Am; 2009 Jun; 23(3):467-80, viii. PubMed ID: 19464597
[TBL] [Abstract][Full Text] [Related]
6. The role of tumor-infiltrating lymphocytes (TILs) as a predictive biomarker of response to anti-PD1 therapy in patients with metastatic non-small cell lung cancer or metastatic melanoma.
Uryvaev A; Passhak M; Hershkovits D; Sabo E; Bar-Sela G
Med Oncol; 2018 Jan; 35(3):25. PubMed ID: 29388007
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating lymphocytes and their significance in melanoma prognosis.
Schatton T; Scolyer RA; Thompson JF; Mihm MC
Methods Mol Biol; 2014; 1102():287-324. PubMed ID: 24258985
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating lymphocytes in patients with metastatic melanoma receiving chemoimmunotherapy.
Hernberg M; Turunen JP; Muhonen T; Pyrhönen S
J Immunother; 1997 Nov; 20(6):488-95. PubMed ID: 9409455
[TBL] [Abstract][Full Text] [Related]
9. Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension?
Heindl LM; Hofmann TN; Adler W; Knorr HL; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2010 Feb; 117(2):334-42. PubMed ID: 19892405
[TBL] [Abstract][Full Text] [Related]
10. Selective growth, in vitro and in vivo, of individual T cell clones from tumor-infiltrating lymphocytes obtained from patients with melanoma.
Zhou J; Dudley ME; Rosenberg SA; Robbins PF
J Immunol; 2004 Dec; 173(12):7622-9. PubMed ID: 15585890
[TBL] [Abstract][Full Text] [Related]
11. Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival.
Bogunovic D; O'Neill DW; Belitskaya-Levy I; Vacic V; Yu YL; Adams S; Darvishian F; Berman R; Shapiro R; Pavlick AC; Lonardi S; Zavadil J; Osman I; Bhardwaj N
Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20429-34. PubMed ID: 19915147
[TBL] [Abstract][Full Text] [Related]
12. [Problems in defining melanoma regression and prognostic implication].
Requena C; Botella-Estrada R; Traves V; Nagore E; Almenar S; Guillén C
Actas Dermosifiliogr; 2009 Nov; 100(9):759-66. PubMed ID: 19889297
[TBL] [Abstract][Full Text] [Related]
13. Tumor-infiltrating lymphocyte response in cutaneous melanoma in the elderly predicts clinical outcomes.
Grotz TE; Vaince F; Hieken TJ
Melanoma Res; 2013 Apr; 23(2):132-7. PubMed ID: 23344159
[TBL] [Abstract][Full Text] [Related]
14. Immunotyping and Quantification of Melanoma Tumor-Infiltrating Lymphocytes.
Meneveau MO; Sahli ZT; Lynch KT; Mauldin IS; Slingluff CL
Methods Mol Biol; 2021; 2265():515-528. PubMed ID: 33704737
[TBL] [Abstract][Full Text] [Related]
15. Reflections on the Histopathology of Tumor-Infiltrating Lymphocytes in Melanoma and the Host Immune Response.
Mihm MC; Mulé JJ
Cancer Immunol Res; 2015 Aug; 3(8):827-35. PubMed ID: 26242760
[TBL] [Abstract][Full Text] [Related]
16. Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response.
Mihm MC; Clemente CG; Cascinelli N
Lab Invest; 1996 Jan; 74(1):43-7. PubMed ID: 8569196
[TBL] [Abstract][Full Text] [Related]
17. Tumor-infiltrating lymphocytes predict cutaneous melanoma survival.
Fortes C; Mastroeni S; Mannooranparampil TJ; Passarelli F; Zappalà A; Annessi G; Marino C; Caggiati A; Russo N; Michelozzi P
Melanoma Res; 2015 Aug; 25(4):306-11. PubMed ID: 25933208
[TBL] [Abstract][Full Text] [Related]
18. The heterogeneity of tumor-infiltrating CD8+ T cells in metastatic melanoma distorts their quantification: how to manage heterogeneity?
Obeid JM; Hu Y; Erdag G; Leick KM; Slingluff CL
Melanoma Res; 2017 Jun; 27(3):211-217. PubMed ID: 28118270
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes.
Romero P; Dunbar PR; Valmori D; Pittet M; Ogg GS; Rimoldi D; Chen JL; Liénard D; Cerottini JC; Cerundolo V
J Exp Med; 1998 Nov; 188(9):1641-50. PubMed ID: 9802976
[TBL] [Abstract][Full Text] [Related]
20. High level of TILs is an independent predictor of negative sentinel lymph node in women but not in men.
Fortes C; Mastroeni S; Caggiati A; Passarelli F; Ricci F; Michelozzi P
Arch Dermatol Res; 2021 Jan; 313(1):57-61. PubMed ID: 32266533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
